Sotera Health Company
SHC · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.05 | -0.62 | 0.30 | -2.82 |
| FCF Yield | 0.75% | 0.83% | 1.08% | -0.26% |
| EV / EBITDA | 57.52 | 54.35 | 80.00 | 47.07 |
| Quality | ||||
| ROIC | 2.49% | 1.24% | 1.76% | 0.82% |
| Gross Margin | 57.04% | 56.61% | 53.21% | 56.64% |
| Cash Conversion Ratio | – | 7.21 | -4.19 | 4.52 |
| Growth | ||||
| Revenue 3-Year CAGR | 5.11% | 4.83% | 3.87% | 3.12% |
| Free Cash Flow Growth | 27.50% | -26.45% | 450.66% | -117.15% |
| Safety | ||||
| Net Debt / EBITDA | 17.65 | 21.19 | 30.54 | 16.42 |
| Interest Coverage | 2.84 | 2.18 | 1.40 | 2.13 |
| Efficiency | ||||
| Inventory Turnover | 2.68 | 2.13 | 1.95 | 2.56 |
| Cash Conversion Cycle | 74.72 | 52.36 | 47.31 | 47.17 |